Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Cirrhosis

  Free Subscription

Articles published in Dig Dis Sci

Retrieve available abstracts of 99 articles:
HTML format

Single Articles

    November 2021
  1. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    PubMed     Abstract available

    October 2021
  2. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    PubMed     Abstract available

    September 2021
  3. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.

    August 2021
  4. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
    Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
    Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
    PubMed     Abstract available

  5. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
    Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
    PubMed     Abstract available

  6. THAKER S, Mikolajczyk AE
    Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.

  7. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
    Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
    PubMed     Abstract available

    July 2021
  8. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    PubMed     Abstract available

  9. BOPPANA V, Sahni S, Glass J, Chang C, et al
    HCC You Cannot See.
    Dig Dis Sci. 2021;66:2185-2189.

    June 2021
  10. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    PubMed     Abstract available

  11. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    PubMed     Abstract available

  12. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    PubMed     Abstract available

  13. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    PubMed     Abstract available

    May 2021
  14. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed     Abstract available

  15. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available

  16. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.

  17. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    PubMed     Abstract available

    April 2021
  18. TROWELL J, Alukal J, Zhang T, Liu L, et al
    How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Dig Dis Sci. 2021;66:1297-1305.
    PubMed     Abstract available

    March 2021
  19. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    PubMed     Abstract available

    January 2021
  20. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    PubMed     Abstract available

  21. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    PubMed     Abstract available

    November 2020
  22. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    PubMed     Abstract available

  23. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    PubMed     Abstract available

  24. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    PubMed     Abstract available

  25. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    PubMed     Abstract available

    October 2020
  26. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    PubMed     Abstract available

    September 2020
  27. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
    Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
    Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
    PubMed     Abstract available

  28. TRIEU H, Patel A, Wells C, Saab S, et al
    Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Sep 14. pii: 10.1007/s10620-020-06582.
    PubMed     Abstract available

  29. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available

  30. SIMONS-LINARES CR, Abushamma S, Romero-Marrero C, Bhatt A, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.
    Dig Dis Sci. 2020 Sep 6. pii: 10.1007/s10620-020-06575.
    PubMed     Abstract available

  31. SHAW J, Patidar KR, Reuter B, Hajezifar N, et al
    Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06583.
    PubMed     Abstract available

  32. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    PubMed     Abstract available

    August 2020
  33. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available

  34. PHAW NA, Dyson JK, Mells G, Jones D, et al
    Understanding Fatigue in Primary Biliary Cholangitis.
    Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
    PubMed     Abstract available

  35. REICHERT MC, Massmann A, Schulz A, Buecker A, et al
    Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06535.
    PubMed     Abstract available

  36. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
    Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
    Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.

  37. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
    High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
    Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
    PubMed     Abstract available

  38. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    PubMed     Abstract available

  39. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
    External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
    PubMed     Abstract available

  40. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
    Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
    PubMed     Abstract available

    July 2020
  41. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    PubMed     Abstract available

  42. XIE X, Dou CY, Zhou Y, Zhou Q, et al
    MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
    PubMed     Abstract available

    June 2020
  43. LOUISSAINT J, Foster C, Harding-Theobald E, Lok AS, et al
    Social Support Does Not Modify the Risk of Readmission for Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2020 Jun 23. pii: 10.1007/s10620-020-06421.
    PubMed     Abstract available

  44. DANFORD CJ, Lee JY, Strohbehn IA, Corey KE, et al
    Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06388.
    PubMed     Abstract available

  45. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
    Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
    PubMed     Abstract available

    May 2020
  46. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.

  47. LUI FH, Ma P, Helmy M, Hu KQ, et al
    Ultrasonographic (US) Two-Dimensional Measurement of Spleen Is Superior to Traditional Length Measurement Alone in Diagnosing Cirrhosis.
    Dig Dis Sci. 2020 May 23. pii: 10.1007/s10620-020-06332.
    PubMed     Abstract available

  48. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.

    April 2020
  49. ACHARYA C, White MB, Fagan A, Sterling RK, et al
    Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
    PubMed     Abstract available

    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.

  51. O'BEIRNE J
    Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
    Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.

  52. TURKSEVEN S, Bolognesi M, Di Pascoli M
    Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Dig Dis Sci. 2020 Apr 2. pii: 10.1007/s10620-020-06233.
    PubMed     Abstract available

  53. TIEN PC, Duarte M, Roque A, Price J, et al
    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?
    Dig Dis Sci. 2020;65:928-930.

    March 2020
  54. PATEL S, Siddiqui MB, Chandrakumaran A, Rodriguez VA, et al
    Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.
    Dig Dis Sci. 2020 Mar 18. pii: 10.1007/s10620-020-06196.
    PubMed     Abstract available

  55. O'LEARY JG, Tandon P, Reddy KR, Biggins SW, et al
    Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06168.
    PubMed     Abstract available

  56. LI J, Dong S, Ye M, Peng G, et al
    MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
    PubMed     Abstract available

  57. ZHANG L, Tai Y, Tang S, Zhao C, et al
    Compromised Ileal Mucus Barrier Due to Impaired Epithelial Homeostasis Caused by Notch1 Signaling in Cirrhotic Rats.
    Dig Dis Sci. 2020 Mar 6. pii: 10.1007/s10620-020-06178.
    PubMed     Abstract available

    February 2020
  58. MELLINGER JL, Stine JG
    Early Liver Transplantation for Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
    PubMed     Abstract available

  59. FRICKER ZP, Mukthinuthalapati VVPK, Akinyeye S, Chalasani N, et al
    MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis.
    Dig Dis Sci. 2020 Feb 25. pii: 10.1007/s10620-020-06164.
    PubMed     Abstract available

  60. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
    A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
    PubMed     Abstract available

  61. WONG K, Podboy A, Lavezo J, Goel A, et al
    Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis.
    Dig Dis Sci. 2020;65:399-400.

    January 2020
  62. MURPHY SL, Richardson JK, Blackwood J, Martinez B, et al
    Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis.
    Dig Dis Sci. 2020 Jan 25. pii: 10.1007/s10620-020-06099.
    PubMed     Abstract available

  63. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
    Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
    Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
    PubMed     Abstract available

  64. SASSO R, Lauzon S, Rockey DC
    Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and Survival.
    Dig Dis Sci. 2020 Jan 20. pii: 10.1007/s10620-020-06051.
    PubMed     Abstract available

  65. GUEDES RR, Kieling CO, Dos Santos JL, da Rocha C, et al
    Severity of Ascites Is Associated with Increased Mortality in Patients with Cirrhosis Secondary to Biliary Atresia.
    Dig Dis Sci. 2020 Jan 6. pii: 10.1007/s10620-019-06029.
    PubMed     Abstract available

  66. ZHAO XM, Zhang J, Liang YN, Niu YC, et al
    Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06017.
    PubMed     Abstract available

  67. ALLEGRITTI M, Enrico B, Basile E, de Vito L, et al
    Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06024.
    PubMed     Abstract available

  68. YIK B, Shah N
    Autoconversion of Autoimmune Liver Diseases.
    Dig Dis Sci. 2020;65:71-73.

  69. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.

    December 2019
  70. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
    Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
    PubMed     Abstract available

  71. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    PubMed     Abstract available

    November 2019
  72. CANNON MD, Martin P, Carrion AF
    Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.
    Dig Dis Sci. 2019 Nov 25. pii: 10.1007/s10620-019-05943.
    PubMed     Abstract available

  73. CHEN Y, Ji H, Shao J, Jia Y, et al
    Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
    PubMed     Abstract available

  74. GOUDRA B, Singh PM
    GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05949.

  75. VUYYURU SK, Singh AD, Gamanagatti SR, Rout G, et al
    A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05939.
    PubMed     Abstract available

  76. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Abstract available

  77. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Abstract available

    October 2019
  78. LING C, Khalid S, Martin D, Hanson J, et al
    HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05920.

  79. HUANG R, Rao H, Yang M, Gao Y, et al
    Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
    PubMed     Abstract available

  80. STINE JG, Intagliata NM, Shah NL, Lisman T, et al
    Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.
    Dig Dis Sci. 2019 Oct 18. pii: 10.1007/s10620-019-05884.
    PubMed     Abstract available

  81. EDELSON J, Suarez AL, Zhang J, Rockey DC, et al
    Sedation During Endoscopy in Patients with Cirrhosis: Safety and Predictors of Adverse Events.
    Dig Dis Sci. 2019 Oct 12. pii: 10.1007/s10620-019-05845.
    PubMed     Abstract available

  82. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Abstract available

    September 2019
  83. GALOOSIAN A, Hanlon C, Tana M, Cheung R, et al
    Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05809.
    PubMed     Abstract available

  84. RAVAIOLI F, Colecchia A
    Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance.
    Dig Dis Sci. 2019;64:2381-2383.

  85. MA J, Qiu Y, Wang M, Zhang M, et al
    Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
    Dig Dis Sci. 2019;64:2570-2580.
    PubMed     Abstract available

    August 2019
  86. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    PubMed     Abstract available

  87. SAYINER M, Stepanova M, De Avila L, Golabi P, et al
    Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Dig Dis Sci. 2019 Aug 27. pii: 10.1007/s10620-019-05786.
    PubMed     Abstract available

  88. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    PubMed     Abstract available

  89. ALI RO, Moon MS, Townsend EC, Hill K, et al
    Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
    Dig Dis Sci. 2019 Aug 12. pii: 10.1007/s10620-019-05760.
    PubMed     Abstract available

  90. HAO YL, Bian ZL, Ju LL, Liu Y, et al
    RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Dig Dis Sci. 2019 Aug 3. pii: 10.1007/s10620-019-05758.
    PubMed     Abstract available

  91. JOSHI SS, Gao S, Castillo E, Coffin CS, et al
    Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
    Dig Dis Sci. 2019 Aug 2. pii: 10.1007/s10620-019-05745.
    PubMed     Abstract available

  92. PHAW NA, Jones DEJ
    PBC: Better Solutions to Beat Feeling Beat.
    Dig Dis Sci. 2019;64:2075-2077.

    July 2019
  93. SAMJI NS, Verma R, Keri KC, Singal AK, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05716.
    PubMed     Abstract available

  94. KUZNIETSOVA HM, Dziubenko NV, Lynchak OV, Herheliuk TS, et al
    Effects of Pristine C60 Fullerenes on Liver and Pancreas in alpha-Naphthylisothiocyanate-Induced Cholangitis.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05730.
    PubMed     Abstract available

    June 2019
  95. KIM DS, Lim TS, Jeon MY, Kim BK, et al
    Transarterial Chemoembolization in Treatment-Naive and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05701.
    PubMed     Abstract available

  96. MANKA P, Bechmann L, Best J, Sydor S, et al
    Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2019 Jun 3. pii: 10.1007/s10620-019-05687.
    PubMed     Abstract available

    April 2019
    Concise Commentary: Staying True to Type-The Increasing Inpatient Burden of Hepatic Encephalopathy.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05630.

    March 2019
  98. HIRODE G, Vittinghoff E, Wong RJ
    Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05576.
    PubMed     Abstract available

    January 2019
  99. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5462.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.